Length of stay following elective craniotomy for tumor resection in children and young adults: a retrospective case series.

IF 3.2 2区 医学 Q2 CLINICAL NEUROLOGY
Journal of Neuro-Oncology Pub Date : 2025-02-01 Epub Date: 2024-11-29 DOI:10.1007/s11060-024-04887-w
Emal Lesha, Jordan T Roach, L Erin Miller, C Stewart Nichols, Brandy Vaughn, David G Laird, Taylor Orr, Delaney Graham, Mustafa Motiwala, Nir Shimony, Paul Klimo
{"title":"Length of stay following elective craniotomy for tumor resection in children and young adults: a retrospective case series.","authors":"Emal Lesha, Jordan T Roach, L Erin Miller, C Stewart Nichols, Brandy Vaughn, David G Laird, Taylor Orr, Delaney Graham, Mustafa Motiwala, Nir Shimony, Paul Klimo","doi":"10.1007/s11060-024-04887-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Length of stay (LOS) is a critical metric of healthcare delivery. Prolonged LOS is associated with a heightened risk of adverse complications. We aimed to provide a comprehensive evaluation of LOS, specifically identifying variables associated with extended LOS (eLOS), in children and young adults following elective craniotomy for tumor resection.</p><p><strong>Methods: </strong>All elective craniotomies for tumor resection performed at our tertiary care children's hospital from January 2010 to December 2022 were included for review, excluding patients > 21 years of age. Demographic, clinical, and procedural variables for each craniotomy were collected. LOS was defined as the interval in days from index surgery to discharge. eLOS was defined as greater than 7 days.</p><p><strong>Results: </strong>1,276 patients underwent a total of 1,497 elective craniotomies for tumor resection. The median age was 9.45 years old, with the most common age group being > 10 years (45.6%). Most patients had supratentorial tumors (63.4%) and underwent de novo surgery (60.7%). Patients with an eLOS experienced longer ICU admissions, longer surgical times, and were younger. Variables found to be significantly associated with eLOS were posterior fossa resection (OR = 2.45), de novo craniotomy (OR = 0.49), prior shunt or ETV (OR = 1.80), tumor type (craniopharyngioma (OR = 3.74) and medulloblastoma (OR = 0.51)), and the presence of at least one postoperative event (POE) (OR = 29.85).</p><p><strong>Conclusion: </strong>This is the largest study evaluating factors (patient, tumor, surgical) associated with eLOS after elective craniotomy for tumor resection in children and young adults. The findings of this clinical study are important for preoperative counseling, neurosurgical team preparedness, and healthcare delivery optimization.</p>","PeriodicalId":16425,"journal":{"name":"Journal of Neuro-Oncology","volume":" ","pages":"651-658"},"PeriodicalIF":3.2000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11729059/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neuro-Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11060-024-04887-w","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/29 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Length of stay (LOS) is a critical metric of healthcare delivery. Prolonged LOS is associated with a heightened risk of adverse complications. We aimed to provide a comprehensive evaluation of LOS, specifically identifying variables associated with extended LOS (eLOS), in children and young adults following elective craniotomy for tumor resection.

Methods: All elective craniotomies for tumor resection performed at our tertiary care children's hospital from January 2010 to December 2022 were included for review, excluding patients > 21 years of age. Demographic, clinical, and procedural variables for each craniotomy were collected. LOS was defined as the interval in days from index surgery to discharge. eLOS was defined as greater than 7 days.

Results: 1,276 patients underwent a total of 1,497 elective craniotomies for tumor resection. The median age was 9.45 years old, with the most common age group being > 10 years (45.6%). Most patients had supratentorial tumors (63.4%) and underwent de novo surgery (60.7%). Patients with an eLOS experienced longer ICU admissions, longer surgical times, and were younger. Variables found to be significantly associated with eLOS were posterior fossa resection (OR = 2.45), de novo craniotomy (OR = 0.49), prior shunt or ETV (OR = 1.80), tumor type (craniopharyngioma (OR = 3.74) and medulloblastoma (OR = 0.51)), and the presence of at least one postoperative event (POE) (OR = 29.85).

Conclusion: This is the largest study evaluating factors (patient, tumor, surgical) associated with eLOS after elective craniotomy for tumor resection in children and young adults. The findings of this clinical study are important for preoperative counseling, neurosurgical team preparedness, and healthcare delivery optimization.

儿童和年轻人择期开颅肿瘤切除术后的住院时间:回顾性病例系列。
目的:住院时间(LOS)是衡量医疗服务质量的关键指标。长期的LOS与不良并发症的高风险相关。我们的目的是对儿童和年轻人择期开颅切除肿瘤后的LOS进行全面评估,特别是确定与延长LOS (eLOS)相关的变量。方法:纳入2010年1月至2022年12月在我院三级儿童医院进行的所有择期开颅肿瘤切除术,排除年龄在bb0 ~ 21岁的患者。收集每次开颅手术的人口学、临床和程序变量。LOS定义为从指数手术到出院的间隔天数。eLOS定义为大于7天。结果:1276例患者共行择期开颅肿瘤切除术1497例。年龄中位数为9.45岁,最常见年龄组为10 ~ 10岁(45.6%)。大多数患者为幕上肿瘤(63.4%),并行从头手术(60.7%)。eLOS患者在ICU住院时间较长,手术时间较长,且年龄较小。与eLOS显著相关的变量包括后颅窝切除术(OR = 2.45)、新开颅术(OR = 0.49)、既往分流术或ETV (OR = 1.80)、肿瘤类型(颅咽管瘤(OR = 3.74)和成神经管细胞瘤(OR = 0.51))以及至少一次术后事件(POE)的存在(OR = 29.85)。结论:这是评估儿童和年轻人择期开颅切除肿瘤后eLOS相关因素(患者、肿瘤、手术)的最大研究。本临床研究结果对术前咨询、神经外科团队准备和医疗服务优化具有重要意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Neuro-Oncology
Journal of Neuro-Oncology 医学-临床神经学
CiteScore
6.60
自引率
7.70%
发文量
277
审稿时长
3.3 months
期刊介绍: The Journal of Neuro-Oncology is a multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neurodiagnosticians, and laboratory-based oncologists conducting relevant research. The Journal of Neuro-Oncology does not seek to isolate the field, but rather to focus the efforts of many disciplines in one publication through a format which pulls together these diverse interests. More than any other field of oncology, cancer of the central nervous system requires multi-disciplinary approaches. To alleviate having to scan dozens of journals of cell biology, pathology, laboratory and clinical endeavours, JNO is a periodical in which current, high-quality, relevant research in all aspects of neuro-oncology may be found.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信